_256_384.jpg)
News | May 04, 2022
Eris Lifesciences acquires Oaknet Healthcare for Rs 650 crore
The deal will be financed by Rs 300 crore of internal accruals and Rs 350 crore of borrowings
The deal will be financed by Rs 300 crore of internal accruals and Rs 350 crore of borrowings
Infigratinib is not FDA-, Health Canada- or Therapeutics Goods Association-approved for any other indication
Onshore manufacturing facility is expected to be based in Quebec and produce up to 100 million mRNA respiratory vaccine doses annually
South Carolina’s largest health system adopts Philips software solutions for patient monitoring and enterprise imaging, helping to drive interoperability and data analytics, and deliver on Quadruple Aim
The management believes that its strong product pipeline, diversified innovative product portfolio, continued expansion into new geographies and FGMP accreditations will help sustain the growth momentum in the coming few years
Beyond the technical leadership from F1, the collaboration will bring a specific focus on the people dimension of high performance
Biocon Biologics’ Insugen formulations will be available to patients at all Ministry of Health hospitals, district health offices and health clinics
This is the first major brand refresh of CanSinoBIO since its inception in 2009
It is a multi-speciality healthcare brand which delivers a hassle-free experience for all types of cosmetic procedures and elective surgeries with personalized care
Erytech is evaluating valuable strategic options to leverage its Erycaps platform and its development and manufacturing capabilities with complementary assets and/or a broader corporate transaction
Subscribe To Our Newsletter & Stay Updated
